Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...
New Zealand is set to sign a free trade agreement next week committing some of our key primary industries to upgrading the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results